Ge W, Yan Y, Hu Y, Lin S, Mao P. Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data. J Alzheimers Dis. 2025 Jan 12;:13872877241307246. Epub 2025 Jan 12 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Leqembi Maintenance Dosing Approved in the U.S.